Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
European Heart Journal
|
May 25, 2026
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
Johan Wouter Jukema, Nicolaas J Van Neer, Michael Szarek, et al.
European Journal of Preventive Cardiology
|
March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
Circulation
|
August 26, 2023
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Michael Szarek, Esther Reijnders, J Wouter Jukema, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Clinical Chemistry
|
January 21, 2026
Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study
Lori B Daniels, Christian Mueller, Evangelos Giannitsis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 19, 2026
Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design
Lori B Daniels, Evangelos Giannitsis, Christian Mueller, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis
|
January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Børge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
European Heart Journal
|
May 25, 2026
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
Johan Wouter Jukema, Nicolaas J Van Neer, Michael Szarek, et al.
European Journal of Preventive Cardiology
|
March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES
Michael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
Circulation
|
August 26, 2023
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests
Michael Szarek, Esther Reijnders, J Wouter Jukema, et al.
European Heart Journal
|
April 29, 2016
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry
|
May 29, 2016
Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Børge G Nordestgaard, Anne Langsted, Samia Mora, et al.
Clinical Chemistry
|
May 16, 2018
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R Langlois, M John Chapman, Christa Cobbaert, et al.
Clinical Chemistry
|
January 21, 2026
Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study
Lori B Daniels, Christian Mueller, Evangelos Giannitsis, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
January 19, 2026
Clinical performance of the next generation Elecsys Troponin T high-sensitivity Gen 6 assay in acute coronary syndrome (PERFORM-TSIX): study design
Lori B Daniels, Evangelos Giannitsis, Christian Mueller, et al.
Clinical Chemistry and Laboratory Medicine
|
December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.
Atherosclerosis
|
January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM
Børge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.
Page
of 6